hsurvivin

General Information


DCTPep ID  DCTPep04865

Peptide Name   hsurvivin

Sequence  FLKDHRISTFKNWPF

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer therapy related peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C94H134N24O21

Absent amino acids  ACEGMQVY

Theoretical pI  9.99

Acidic residues  1

Basic residues  4

Polar residues  3

Molecular weight (Average)  1936.25

Molecular weight (Monoisotopic)  1935.02

Common amino acids  F

Net charge  3

Instability index (II)  7.81

Aliphatic index  52.00

Grand average of hydropathicity (GRAVY)  -0.653

Half Life 
  1.1 hours (mammalian reticulocytes, in vitro).
  3 min (yeast, in vivo).
  2 min (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 5500
  Abs 0.1% (=1 g/l) 2.841

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 17142738

Title  Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin

Doi 10.4049/jimmunol.177.12.8410

Year  2006

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.